Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Pancreatic cancer study reveals the cause of tumor cell resistance to immunotherapy

Pancreatic cancer study reveals the cause of tumor cell resistance to immunotherapy

Combination of targeted therapies with immunotherapy addresses treatment resistance in pancreatic cancer

Combination of targeted therapies with immunotherapy addresses treatment resistance in pancreatic cancer

Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma

Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma

Research reveals the cellular origin of cancer-associated fibroblasts

Research reveals the cellular origin of cancer-associated fibroblasts

Study reveals how most-resistant pancreatic cancer cells defy treatment

Study reveals how most-resistant pancreatic cancer cells defy treatment

Cancer mortality in the U.S. has declined 33% since the 90s

Cancer mortality in the U.S. has declined 33% since the 90s

New molecular pathway critical to the initiation of pancreatic tumors discovered

New molecular pathway critical to the initiation of pancreatic tumors discovered

CAR T cell therapy may enhance the effectiveness of surgery for solid tumors

CAR T cell therapy may enhance the effectiveness of surgery for solid tumors

UC researcher focuses on studying how gene mutations help pancreatic cancer grow

UC researcher focuses on studying how gene mutations help pancreatic cancer grow

Drug combination elicits efficacious anti-tumor immunity against immunotherapy-resistant cancers

Drug combination elicits efficacious anti-tumor immunity against immunotherapy-resistant cancers

Clinically relevant biomarker strategies in drug development

Clinically relevant biomarker strategies in drug development

Historic agreement to accelerate trials into vaccines for cancer and wider diseases

Historic agreement to accelerate trials into vaccines for cancer and wider diseases

Novel triple immunotherapy combination improves anti-tumor responses in preclinical models of pancreatic cancer

Novel triple immunotherapy combination improves anti-tumor responses in preclinical models of pancreatic cancer

Researchers identify novel gene mechanism in most aggressive kidney cancers

Researchers identify novel gene mechanism in most aggressive kidney cancers

Phase I clinical trial of PAC-1 in patients with end-stage cancers shows promising results

Phase I clinical trial of PAC-1 in patients with end-stage cancers shows promising results

Sotorasib achieves meaningful anticancer activity in patients with KRAS G12C-mutated metastatic pancreatic cancer

Sotorasib achieves meaningful anticancer activity in patients with KRAS G12C-mutated metastatic pancreatic cancer

PCOS increases risk of pancreatic cancer

PCOS increases risk of pancreatic cancer

New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer

New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer

BGI cares - 2022 social responsibilities in review

BGI cares - 2022 social responsibilities in review

Novel immunotherapy offers a promising new strategy to fight hard-to-treat cancers

Novel immunotherapy offers a promising new strategy to fight hard-to-treat cancers